SEARCH

SEARCH BY CITATION

References

  • ABBRACCHIO, M.P. & BURNSTOCK, G.(1994). Purinoceptors: Are there families of P2X and P2Y purinoceptors Pharmacol. Ther., 64, 445475.
  • BALLERINI, P., RATHBONE, M.P., DIIORIO, P., RENZETTI, A., GIULIANI, P., D'ALIMONTE, I., TRUBIANI, O., CACIAGLI, F. & CICCARELLI, R.(1996). Rat astroglial P2Z (P2X7) receptors regulate intracellular calcium and purine release. NeuroReport, 7, 25332537.
  • BEAN, B.P.(1992). Pharmacology and electrophysiology of ATP-activated ion channels. TIPS, 13, 8790.
  • BENHAM, C.D.(1992). ATP joins the fast lane. Nature, 359, 103104.
  • BIANCHI, B.R., LYNCH, K.J., TOUMA, E., NIFORATOS, W., BURGARD, E.C., ALEXANDER, K.M., PARK, H.S., YU, H., METZGER, R., KOWALUK, E., JARVIS, M.F. & VAN BIESEN, T.(1999). Pharmacological characterization of recombinant human and rat P2X receptor subtypes. Eur. J. Pharmacol., 376, 127138.
  • BLAUSTEIN, M.P.(1975). Effects of potassium, veratridine and scorpion venom on Ca2+ accumulation and transmitter release by nerve terminals in vitro. J. Physiol., 247, 617655.
  • BOEHM, S.(1999). ATP stimulates sympathetic transmitter release via presynaptic P2X receptors. J. Neurosci., 19, 737746.
  • BOEHM, S., HUCK, S. & ILLES, P.(1995). UTP and ATP-triggered transmitter release from rat sympathetic neurones via separate receptors. Br. J. Pharmacol., 116, 23412343.
  • BRADFORD, M.M.(1976). A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein dye binding. Anal. Biochem., 72, 248254.
  • BRAKE, A.J., WAGENBACH, M.J. & JULIUS, D.(1994). New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature, 371, 519523.
  • BROOK, G.A., LAWRENCE, J.M. & RAISMAN, G.(2001). Columns of schwann cells extruded into the CNS induce in-growth of astrocytes to form organized new glial pathways. Glia, 33, 118130.
  • BURNSTOCK, G.(1999). Current status of purinergic signalling in the nervous system. In Progress in Brain Research: Nucleotides and their receptors in the nervous system. eds, Illes P, Zimmerman H. vol. 120. pp. 310. Amsterdam: Elsevier.
  • CHESSELL, I.P., MICHEL, A.D. & HUMPHREY, P.P.A.(1998). Effects of antagonists at the human recombinant P2X7 receptor. Br. J. Pharmacol., 124, 13141320.
  • CHUNG, H.S., PARK, K.S., CHA, S.K., KONG, I.D. & LEE, J.W.(2000). ATP-induced [Ca2+]i changes and depolarization in GH3 cells. Br. J. Pharmacol., 130, 18431852.
  • COLLO, G., NEIDHART, E., KAWASHIMA, M., KOSCO-VILBOIS, M., NORTH, R.A. & BUELL, G.N.(1997). Tissue distribution of the P2X7 receptor. Neuropharmacology, 36, 12771283.
  • COLLO, G., NORTH, R.A., KAWASHIMA, E., MERLO-PICH, E., NEIDHART, S., SURPRENANT, A. & BUELL, G.(1996). Cloning of P2X5 and P2X6 receptors, and the distribution and properties of an extended family of ATP-gated ion channels. J. Neurosci., 16, 24952507.
  • DANIELS, K.K. & VICKROY, T.W.(1998). Simultaneous isolation of glial and neuronal fractions from rat brain homogenates: Comparison of high-affinity L-glutamate transport properties. Neurochem. Res., 23, 103113.
  • DIÁZ-HERNÁNDEZ, M., GÓMEZ-VILLAFUERTES, R., HERNANDO, F., PINTOR, J. & MIRAS-PORTUGAL, M.T.(2001). Presence of different ATP receptors on rat midbrain single synaptic terminals. Involvement of the P2X3 subunits. Neurosci. Lett., 301, 159162.
  • DUGAR, A., PATANOW, C., O'CALLAGHAN, J.P. & LAKOSKI, J.M.(1998). Immunohistochemical localisation and quantification of glial fibrillary acidic protein (mol wt 25,000) in the aging hippocampus following administration of 5,7-dihydroxytryptamine. Neuroscience, 85, 123133.
  • DUNKLEY, P.R., HEATH, J.W., HARRISON, S.M., JARVIEM, P.E., GLENFIELD, P.J. & ROSTAS, J.A.P.(1988). A rapid Percoll gradient procedure for isolation of synaptosomes directly from an S1 fraction: homogeneity and morphology of subcellular fractions. Brain Res., 441, 5971.
  • EDWARDS, F.A., GIBB, A.J. & COLQUHOUN, D.(1992). ATP receptor mediated synaptic currents in the central nervous system. Nature, 359, 144147.
  • EVANS, R.J., DERKACH, V. & SURPRENANT, A.(1992). ATP mediates fast synaptic transmission in mammalian neurons. Nature, 357, 503505.
  • EVANS, R.J., SURPRENANT, A. & NORTH, R.A.(1998). P2X receptors cloned and expressed. In The P2 Nucleotide Receptors., eds. Turner JT, Weisman GA, Fedan JS. pp. 4361. Totawa, NJ: Humana Press.
  • FERRARI, D., CHIOZZI, P., FALZONI, S., DAL SUSINO, M., COLLO, G., BUELL, G. & DI VIRGILLIO, F.(1997). ATP-mediated cytotoxicity in microglial cells. Neuropharmacology, 36, 12951301.
  • FREDHOLM, B.B., ABBRACCHIO, M.P., BURNSTOCK, G., DALY, J.W., HARDEN, T.K., JACOBSON, K.A., LEFF, P. & WILLIAMS, M.(1994). VI Nomenclature and classification of purinoceptors. Pharmacol. Rev., 46, 143156.
  • FREDHOLM, B.B., ABBRACCHIO, M.P., BURNSTOCK, G., DUBYAK, G.R., HARDEN, T.K., JACOBSON, K.A., SCHWABE, U. & WILLIAMS, M.(1997). Towards a revised nomenclature for P1 and P2 receptors. TIPS, 18, 7982.
  • GALLIGAN, J.J. & BERTRAND, P.P.(1994). ATP mediates fast synaptic potentials in enteric neurons. J. Neurosci., 14, 75637571.
  • GARGETT, C.E. & WILEY, J.S.(1997). The isoquinoline derivative KN-62 a potent antagonist of the P2Z receptor of human lymphocytes. Br. J. Pharmacol., 120, 14831490.
  • GIBB, A.J. & HALLIDAY, F.C.(1996). Fast purinergic transmission in the central nervous system. Sem. Neurosc., 8, 225232.
  • GÓMEZ-VILLAFUERTES, R., GUALIX, J. & MIRAS-PORTUGAL, M.T.(2001). Single GABAergic synaptic terminals from rat midbrain exhibit functional P2X and dinucleotide receptors, able to induce GABA secretion. J. Neurochem., 77, 8493.
  • GU, G. & MACDERMOTT, A.B.(1997). Activation of ATP P2X receptors elicits glutamate release from sensory neuron synapses. Nature, 389, 749753.
  • HIBELL, A.D., THOMPSON, K.M., XING, M., HUMPHREY, P.P.A. & MICHEL, A.D.(2001). Complexities of measuring antagonist potency at P2X7 receptor orthologs. J. Pharmacol. Exp. Ther., 296, 947957.
  • HILLYARD, D.R., MONJE, V.D., MINTZ, I.M., BEAN, B.P., NADASDI, L., RAMACHANDRAN, J., MILJANICH, G., AZIMI-ZOONOOZ, A., MCINTOSH, J.M., CRUZ, L.J., IMPERIAL, J.S. & OLIVERA, B.M.(1992). A new conus peptide ligand for mammalian presynaptic Ca2+ channels. Neuron, 9, 6977.
  • HOOGLAND, G., BLOMENROHR, M., DIJSLBLOEM, H., DE WIT, M., SPIERENBURG, H.A., VAN VEELEN, C.W.M., VAN RIJEN, P.C., VAN HUFFELEN, A.C., GISPEN, W.H. & DE GRAAN, P.N.E.(1999). Characterization of neocortical and hippocampal synaptosomes from temporal lobe epilepsy patients. Brain Res., 837, 5566.
  • HUGEL, S. & SCHLICTER, R.(2000). Presynaptic P2X receptors facilitate inhibitory GABAergic transmission between cultured rat spinal cord dorsal horn neurons. J. Neurosci., 20, 21212130.
  • HUMPHREYS, B.D., VIRGINIO, C., SURPRENANT, A., RICE, J. & DUBYAK, G.R.(1998). Isoquinolines as antagonists of the P2X7 nucleotide receptor: High selectivity for the human versus rat receptor homologues. Mol. Pharmacol., 58, 8288.
  • JIANG, L-H., MACKENZIE, A.B., NORTH, R.A. & SURPRENANT, A.(2000). Brilliant blue G selectively blocks ATP-gated rat P2X7 receptors. Mol. Pharmacol., 58, 8288.
  • KANJHAN, R., HOUSLEY, G.D., BURTON, L.D., CHRISTIE, D.L., KIPPENBERGER, A., THORNE, P.R., LUO, L. & RYAN, A.F.(1999). Distribution of the P2X2 receptor subunit of the ATP-gated ion channels in the rat central nervous system. J. Comp. Neurol., 407, 1132.
  • KASAKOV, L. & BURNSTOCK, G.(1983). The use of the slowly degradable analog α,β methylene ATP, to produce desensitization of the P2 purinoceptor: effect of non-adrenergic, non cholinergic responses of the guinea-pig urinary bladder. Eur. J. Pharmacol., 86, 291294.
  • KHAKH, B.S. & HENDERSON, G.(1998). ATP receptor mediated enhancement of fast excitatory neurotransmitter release in the brain. Mol. Pharmacol., 54, 372378.
  • KHAKH, B.S. & HENDERSON, G.(2000). Modulation of fast synaptic transmission by presynaptic ligand-gated cation channels. J. Aut. Nerv. Syst., 81, 110121.
  • KIDD, E.J., GRAHAMES, B.A., SIMON, J., MICHEL, A.D., BARNARD, E.A. & HUMPHREY, P.P.A.(1995). Localization of P2x purinoceptor transcripts in the rat nervous system. Mol. Pharmacol., 48, 569573.
  • KIDD, E.J., MILLER, K.J., SANSUM, A.J. & HUMPHREY. P.P.A.(1998). Evidence for P2X3 receptors in the developing brain. Neuroscience, 87, 533539.
  • KING, B.F., ZIGANSHINA, L.E., PINTOR, J. & BURNSTOCK, G.(1996). The sensitivity of P2X2 purinoceptor to ATP revealed by changing extracellular pH. Br. J. Pharmacol., 117, 13711373.
  • LAMBRECHT, G.(1996). Design and pharmacology of selective P2 purinoceptor antagonists. J. Aut. Pharmacol., 16, 341344.
  • LÊ, K.T., VILLENEUVE, P., RAMJAUN, A.R., MCPHERSON, P.S., BEAUDET, A. & SEGUELA, P.(1998). Sensory presynaptic and widespread somatodendritic immunolocalisation of central ionotropic P2X ATP receptors. Neuroscience, 83, 177190.
  • LUNDY, P.M. & FREW, R.(1996). Review: Ca2+ channel sub-types in peripheral efferent autonomic nerves. J. Aut. Pharmacol., 16, 229241.
  • LUNDY, P.M., FREW, R., FULLER, T.W. & HAMILTON, M.G.(1991). Pharmacological evidence of an ω-conotoxin, dihydropyridine-insensitive neuronal Ca2+ channel. Eur. J. Pharmacol. (Mol. Pharmacol.), 206, 6168.
  • LUNDY, P.M., HAMILTON, M.G. & FREW, R.(1994). Pharmacological identificationof a novel Ca2+ channel in chicken brain synaptosomes. Brain Res., 643, 204210.
  • MOTIN, I. & BENNETT, M.R.(1995). Effect of P2-purinoceptor antagonists on glutamatergic transmission in the rat hippocampus. Br. J. Pharmacol., 115, 12761280.
  • MICHEL, A.D., CHESSELL, I.P. & HUMPHREY, P.P.A.(1999). Ionic effects on human recombinant P2X7 function. Naunyn-Schmied. Arch. Pharmacol., 359, 102109.
  • MICHEL, A.D., CHESSELL, I.P., SIMON, J. & HUMPHREY, P.P.A.(1998). Identification and characterization of an endogenous P2X7 (P2Z) receptor in CHO-K1 cells. Br. J. Pharmacol., 125, 11941201.
  • MICHEL, A.D., GRAHAMES, C.B.A. & HUMPHREY, P.P.A.(1996). Functional characterisation of P2 purinoceptors in PC12 cells by measurement of radiolabelled calcium influx. Naunyn-Schmied. Arch. Pharmacol., 354, 562571.
  • MURGIA, M., HANAU, S., PIZZO, P., RIPPA, M. & DI VIRGILIO, F.(1993). Oxidised ATP, an irreversible inhibitor of the macrophage purinergic P2Z receptor. J. Biol. Chem., 268, 81998203.
  • NÖRENBERG, W. & ILLES, P.(2000). Neuronal P2X receptors: localisation and functional properties. Naunyn-Schmied. Arch. Pharmacol., 362, 324339.
  • NUTTLE, L.C. & DUBYAK, G.R.(1994). Differential activation of cation channels and non-selective pores by macrophage P2Z purinergic receptors expessed in Xenopus oocytes. J. Biol. Chem., 269, 1398813996.
  • PINTOR, J., DÍAZ-HERNÁNDEZ, M., BUSTAMANTE, C., GUALIX, J., GÓMEZ DE TERREROS, F.J. & MIRAS-PORTUGAL, M.T.(1999). Presence of dinucleotide and ATP receptors in human cerebrocortical synaptic terminals. Eur. J. Pharmacol., 366, 159165.
  • ROGERS, M., COLQUHOUN, L.M., PATRICK, J.W. & DANI, J.A.(1997). Ca2+ flux through predominantly independent purinergic ATP and nicotinic acetylcholine receptors. J. Neurophysiol., 77, 14071417.
  • SÉGUÉLA, P., HAGHIGHI, A., SOGHOMONIAN, J-J. & COOPER, E.(1996). A novel neuronal P2x ATP receptor ion channel with widespread distribution in the brain. J. Neurosci., 16, 448455.
  • SILINSKY, E.M., GERZANICH, V. & VANNER, S.M.(1992). ATP mediates fast excitatory synaptic transmission in enteric neurones. Br. J. Pharmacol., 106, 762763.
  • SPERLÁGH, B., ERDELYI, F., SZABÓ, G. & VIZI, E.S.(2000). Local regulation of 3[H]-noradrenaline release from the isolated guinea-pig right atrium by P2x receptors located on axon terminals. Br. J. Pharmacol., 131, 17751783.
  • SURPRENANT, A., RASSENDREN, F., KAWASHIMA, E., NORTH, R.A. & BUELL, G.(1996). The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science, 272, 735737.
  • TROADEC, J-D, THIRION, S., NICAISE, G., LEMOS, J.R. & DAYANITHI, G.(1998). ATP-evoked increases in [Ca2+]I and peptide release from rat isolated neurohypophysial terminals via a P2×2 purinoceptor. J. Physiol., 511, 89108.
  • UENO, S., HARATA, N., INOUE, K. & AKAIKE, N.J.(1992). ATP-gated current in dissociated rat nucleus solitarii neurons. J. Neurophysiol., 68, 778785.
  • VALERA, S., HUSSY, N., EVANS, R.J., ADAMI, N., NORTH, R.A., SURPRENANT, A. & BUELL, G.(1994). A new class of ligand-gated ion channel defined by a P2X receptor for extracellular ATP. Nature, 371, 516519.
  • VIRGINIO, C., CHURCH, D., NORTH, R.A. & SURPRENANT, A.(1997). Effects of divalent cations and protons and calmidazolium at the rat P2X7 receptor. Neuropharmacology, 36, 12851294.
  • VON KÜLGELGEN, I., KURZ, K. & STARKE, K.(1993). Axon terminal P2-purinoceptors in feedback control of sympathetic transmitter release. Neuroscience, 56, 263267.
  • VON KÜLGELGEN, I., NORENBERG, W., MEYER, A., ILLES, P. & STARKE, K.(1999). Role of action potentials and Ca2+ influx in ATP- and UDP-induced noradrenaline release from rat cultured sympathetic neurones. Naunyn- Schmeid. Arch. Pharmacol., 359, 360369.
  • WATLING, K.J.(1998). P2 receptors. In The RBI Handbook of Receptor Classification and Signal Transduction. 3rd edn. pp. 5860. Natick, MA: RBI.
  • WHEELER, D.B., RANDALL, A. & TSIEN, R.W.(1996). Roles of N-type and Q-type Ca2+ channels in supporting hippocampal synaptic transmission. Science, 264, 107111.
  • WILEY, J.S., CHEN, J.R., SNOOK, M.S., GARGETT, C.E. & JAMIESON, G.P.(1996). Transduction mechanisms of P2Z purinoceptors. In: P2 Purinoceptors: Localization, Function and Transduction Mechanisms. pp. 149–165. Chichester: Wiley.
  • WILEY, J.S., CHEN, J.R., WILEY, M.J. & JAMIESON, G.P.(1992). The ATP4- receptor-operated ion channel of human lymphocytes: inhibition of ion fluxes by ameloride analogues and by extracellular sodium ions. Biochem. Biophys., 292, 411418.
  • WILEY, J.S., GARGETT, C.E., ZHANG, W., SNOOK, M.B. & JAMIESON, G.P.(1998). Partial agonists and antagonists reveal a second permeability state of human lymphocyte P2Z/P2X7 channel. Am. J. Physiol., 275, C1224C1231.